LSX Congress USA 2026

LSX Congress USA is a leading event focused on the US life sciences sector, bringing together biotech leaders, pharma executives and active investors.

Hynes Convention Center, Boston

Dates
Sept 22–24, 2026
Venue
Hynes Convention Center, Boston
Senior Attendees
1,000+
Investors
300+

TL;DR

  • LSX Congress USA 2026 runs September 22-24 in Boston, with Forums on September 22 and the Congress on September 23-24.
  • The event is held at the Hynes Convention Center.
  • Organizer figures put attendance at 1,000+ senior attendees, 300+ investors and 180+ expert speakers.
  • The agenda spans 4 forums and workshops across 5 content streams, with 2,000+ scheduled 1:1 partnering meetings.

About

LSX Congress USA is where biotech companies at different stages of growth meet the investors and pharma partners who can help shape what comes next. It is designed for founders, CEOs and senior executives raising capital, pursuing strategic partnerships and preparing for their next phase of growth. The 2026 edition runs alongside Biotech Week Boston, a broader gathering of 5,000+ pharma, biotech, investor, academic and solution provider attendees from September 22-25.

Who you'll find in the room

Biotech founders and executives

Founders, CEOs and senior executives raising capital or pursuing strategic partnerships attend to connect with investors and pharma partners.

Active investors

Active investors attend to source biotech partnering and investment opportunities in the life sciences sector.

Pharma executives

Pharma executives and leaders attend to identify licensing and partnering opportunities with biotech companies.

Featured speakers

9 listed

Rachel Strick

VP, Business Development & Acquisitions · AbbVie

David Lee

EVP & US CEO · Servier Pharmaceuticals

Curt LaBelle

Managing Partner & Head, AXA IM Global Health Investment Fund · BNP Paribas Asset Management

Kiran Reddy

Senior Managing Director · Blackstone Life Sciences

Christopher Tan

Executive Director, BD&L · Merck & Co., Inc

Elena Diez Cecilia

Senior Director External Innovation DPDS · Johnson & Johnson

Scott Miller

Executive Director, Alliance and Innovation Management · Eli Lilly

Mankit Law

Senior Director – BD, Search & Evaluation · GSK

Bernard Cooney

Partner · Casdin Capital

What attendees say

LSX knows its audience, investors, strategic partners and start ups. They do a great job of meeting their needs.

Maria Shepherd — President, Medi-Vantage LLC

Questions people ask

7 answered

LSX Congress USA 2026 runs September 22-24, 2026, in Boston. Forums take place on September 22, and the Congress runs September 23-24.

LSX Congress USA draws 1,000+ senior attendees, 300+ investors and 180+ expert speakers. The agenda includes 2,000+ scheduled 1:1 partnering meetings across 4 forums and workshops and 5 content streams.

LSX Congress USA 2026 is held at the Hynes Convention Center in Boston, USA.

LSX Congress USA connects biotech companies at different stages of growth with the investors and pharma partners who can help shape what comes next. The event draws 1,000+ senior attendees and 300+ investors.

Confirmed 2026 speakers span pharma business development and alliance roles at AbbVie, Merck, Johnson & Johnson, Eli Lilly, GSK and Servier Pharmaceuticals. Investor-side speakers include Blackstone Life Sciences, BNP Paribas Asset Management and Casdin Capital.

Whether LSX Congress USA is worth attending depends on your goals. Biotech founders and executives seeking investor and pharma partnering meetings, and investors or pharma teams scouting deals, are the strongest fit; general life sciences interest alone is a weaker case given the event's dealmaking focus.

Business or business casual attire is standard for partnering-focused life sciences conferences like this. The organizer does not publish a specific dress code for LSX Congress USA.

Related events

Find more events with this kind of reach.

We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.